Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 12/2000

01-02-2000 | ORIGINAL ARTICLE

Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens

Authors: Craig L. Slingluff Jr., Teresa A. Colella, Lee Thompson, D. David Graham, Jonathan C.A. Skipper, Jennifer Caldwell, Larry Brinckerhoff, David J. Kittlesen, Donna H. Deacon, Correen Oei, Nancy L. Harthun, Eric L. Huczko, Donald F. Hunt, Tim L. Darrow, Victor H. Engelhard

Published in: Cancer Immunology, Immunotherapy | Issue 12/2000

Login to get access
Metadata
Title
Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens
Authors
Craig L. Slingluff Jr.
Teresa A. Colella
Lee Thompson
D. David Graham
Jonathan C.A. Skipper
Jennifer Caldwell
Larry Brinckerhoff
David J. Kittlesen
Donna H. Deacon
Correen Oei
Nancy L. Harthun
Eric L. Huczko
Donald F. Hunt
Tim L. Darrow
Victor H. Engelhard
Publication date
01-02-2000
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 12/2000
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s002620050015

Other articles of this Issue 12/2000

Cancer Immunology, Immunotherapy 12/2000 Go to the issue

OriginalPaper

1999 REVIEWERS

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine